Model-Informed Precision Dosing Software Tools for Dosage Regimen Individualization: A Scoping Review

Abstract

Background: Pharmacokinetic nomograms, equations, and software are considered the main tools available for Therapeutic Drug Monitoring (TDM). Model-informed precision dosing (MIPD) is an advanced discipline of TDM that allows dose individualization, and requires a software for knowledge integration and statistical calculations. Due to its precision and extensive applicability, the use of these software is widespread in clinical practice. However, the currently available evidence on these tools remains scarce. Objectives: To review and summarize the available evidence on MIPD software tools to facilitate its identification, evaluation, and selection by users. Methods: An electronic literature search was conducted in MEDLINE, EMBASE, OpenAIRE, and BASE before July 2022. The PRISMA-ScR was applied. The main inclusion criteria were studies focused on developing software for use in clinical practice, research, or modelling. Results: Twenty-eight software were classified as MIPD software. Ten are currently unavailable. The remaining 18 software were described in depth. It is noteworthy that all MIPD software used Bayesian statistical methods to estimate drug exposure and all provided a population model by default, except NONMEN. Conclusions: Pharmacokinetic software have become relevant tools for TDM. MIPD software have been compared, facilitating its selection for use in clinical practice. However, it would be interesting to standardize the quality and validate the software tools.

Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review

“…Combining PopPK models, individual patient factors and the measured drug concentration, Bayesian estimation can make a prediction of the complete concentration-time profile for patients. 73 Recently, model-informed precision dosing (MIPD), an approach to integrate TDM and PopPK, has gained increasing popularity, since it helps to maximize the success of PK/PD target attainment, and therefore maximize the efficacy and minimize the probability of toxicity. 74 Tools such as Autokinetics, BestDose, and NextDose for real-time MIPD of multiple drugs have been gradually applied in clinical practice.…”

Protocol to build a drug-testing pipeline using large populations of Drosophila melanogaster

“…Active research to determine optimal, individualized drug dosage through direct monitoring has been recently reviewed. 25 , 26 CRITICAL: Solvents may have biological effects independent of the compounds tested, that has been documented well for DMSO. 27 Thus, proper vehicle controls carried out identically and synchronously are crucial to interpret results correctly.…”

“…Active research to determine optimal, individualized drug dosage through direct monitoring has been recently reviewed. 25 , 26 …”

Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation—A Step toward Correct Dosing

“…Furthermore, the integration of the Bayesian approach with PopPK models and coupled with TDM is the cornerstone of the model-informed precision dosing (MIPD) concept. Hence, MIPD facilitates the more precise attainment of PK/PD targets in individual patient, maximizing the efficacy and minimizing the probability of antibiotic toxicity [ 29 , 30 , 31 ].…”